BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Made Scientific and CARR Biosystems Establish Partnership to Advance Scalable MSC and Allogeneic Cell Therapy Manufacturing

  October 26, 2026

   · 

  5 min read
• Press Releases

  Northwest Biotherapeutics Announces Expansion of Its Technical Team

  October 26, 2026

   · 

  5 min read
• Press Releases

  Biogen Canada Provides Update on CDA Draft Recommendation Supporting Expanded Public Reimbursement of SPINRAZA™ for Canadians with SMA

  October 26, 2026

   · 

  4 min read
• Press Releases

  Next-Gen Drug Significantly Prevents Return of and Death From Endometrial Cancer

  October 26, 2026

   · 

  6 min read
• Press Releases

  Biocom Announces the 11th Annual Life Science Catalyst Award Winners

  October 26, 2026

   · 

  3 min read
• Press Releases

  Novo Nordisk A/S - share repurchase programme - October 26, 2026

  October 26, 2026

   · 

  2 min read
• Press Releases

  Lilly declares fourth-quarter 2026 dividend

  October 26, 2026

   · 

  2 min read
• Press Releases

  Sacituzumab Tirumotecan (Sac-TMT) Reduced the Risk of Death by 32% and the Risk of Disease Progression or Death by 41% Compared to Chemotherapy in Certain Patients With Advanced or Recurrent Endometrial Cancer

  October 26, 2026

   · 

  12 min read
• Press Releases

  KEYTRUDA® (pembrolizumab) as Monotherapy Reduced the Risk of Disease Progression or Death by 43% for Certain Patients With Advanced or Recurrent Endometrial Cancer With Mismatch Repair Deficient (dMMR) Tumors Compared to Chemotherapy

  October 26, 2026

   · 

  19 min read
• Press Releases

  Citius Oncology Reports Continued Institutional Demand and 120% Growth in Shipments of LYMPHIR® Units to U.S. Wholesalers During the Fiscal Fourth Quarter of 2026

  October 26, 2026

   · 

  7 min read